Patents by Inventor Michael Staszak

Michael Staszak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6429317
    Abstract: The present invention provides novel indane-like compounds which can be useful for treating psychosis and other conditions associated with the modulation of a muscarinic receptor. The invention provides formulations and methods for using the novel compounds.
    Type: Grant
    Filed: September 5, 2000
    Date of Patent: August 6, 2002
    Assignee: Eli Lilly and Company
    Inventors: Sean P. Hollinshead, Michael A. Staszak, John S. Ward, Joseph W. Wilson, Bret E. Huff, Philip F. Hughes, Jose S. Mendoza, Charles H. Mitch
  • Patent number: 6211364
    Abstract: The present invention provides intermediate for the preparation of indane-like compounds which are useful for the modulation of a muscarinic receptor.
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: April 3, 2001
    Assignee: Eli Lilly and Company
    Inventors: Bret E Huff, Michael A Staszak, John S Ward
  • Patent number: 5977062
    Abstract: The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity against a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.
    Type: Grant
    Filed: April 17, 1998
    Date of Patent: November 2, 1999
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Bret E. Huff, Thalia I. Nicas, John T. Quatroche, Michael J. Rodriguez, Nancy J. Snyder, Michael A. Staszak, Richard C. Thompson, Stephen C. Wilkie, Mark J. Zweifel
  • Patent number: 5843889
    Abstract: The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity aginst a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: December 1, 1998
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Bret E. Huff, Thalia I. Nicas, John T. Quatroche, Michael J. Rodriguez, Nancy J. Snyder, Michael A. Staszak, Richard C. Thompson, Stephen C. Wilkie, Mark J. Zweifel
  • Patent number: 5840684
    Abstract: The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity against a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: November 24, 1998
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Bret E. Huff, Thalia I. Nicas, John T. Quatroche, Michael J. Rodriguez, Nancy J. Snyder, Michael A. Staszak, Richard C. Thompson, Stephen C. Wilkie, Mark J. Zweifel
  • Patent number: 5716112
    Abstract: A traction stud for an endless snowmobile belt including an elongate rod having a ground engagable end and a threaded end which can be coupled to the track with a threaded fastener. A slot is cut into the threaded portion of the track such that the terminal end threaded portion is separated from the remaining threaded portion by a gap but coupled thereto via a reduced stem which, after installation, can be broken away so that the remaining portion of the stud shank is flush with the fastener. The invention also contemplates the method of making the stud and the method of installing the stud with a transverse slot providing a weakened break away portion which can be severed by the application of transverse force to remove the axially inner terminal end of the stud.
    Type: Grant
    Filed: August 7, 1996
    Date of Patent: February 10, 1998
    Assignee: International Engineering & Manufacturing Inc.
    Inventor: Michael Staszak
  • Patent number: 5530009
    Abstract: This invention provides novel compound of the formula ##STR1## which is neurokinin receptor antagonist.
    Type: Grant
    Filed: June 5, 1996
    Date of Patent: June 25, 1996
    Assignee: Eli Lilly and Company
    Inventors: Sung Yong S. Cho, James D. Copp, Francis O. Ginah, Guy J. Hansen, Philip A. Hipskind, Bret E. Huff, Michael J. Martinelli, Michael A. Staszak, Roger W. Tharp-Taylor
  • Patent number: 5142038
    Abstract: Enantiomerically pure .beta.-lactam intermediates of the formula (I) ##STR1## are isolated from a haloalkane solvent through precipitation with methyl-t-butyl ether or methanol. The products thus obtained are key intermediates in the synthesis of antibiotic aagents. The process is appropriate for large scale production.
    Type: Grant
    Filed: July 23, 1991
    Date of Patent: August 25, 1992
    Assignee: Eli Lilly and Company
    Inventors: Christopher W. Doecke, Jeffrey N. Levy, Wayne D. Luke, Michael A. Staszak
  • Patent number: D392925
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: March 31, 1998
    Assignee: International Engineering and Manufacturing Inc.
    Inventor: Michael Staszak